514 related articles for article (PubMed ID: 33923802)
21. Effect of clopidogrel treatment on stress-induced platelet activation and myocardial ischemia in aspirin-treated patients with stable coronary artery disease.
Perneby C; Wallén NH; Hofman-Bang C; Tornvall P; Ivert T; Li N; Hjemdahl P
Thromb Haemost; 2007 Dec; 98(6):1316-22. PubMed ID: 18064330
[TBL] [Abstract][Full Text] [Related]
22. Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis.
Giuliano M; Schettini F; Rognoni C; Milani M; Jerusalem G; Bachelot T; De Laurentiis M; Thomas G; De Placido P; Arpino G; De Placido S; Cristofanilli M; Giordano A; Puglisi F; Pistilli B; Prat A; Del Mastro L; Venturini S; Generali D
Lancet Oncol; 2019 Oct; 20(10):1360-1369. PubMed ID: 31494037
[TBL] [Abstract][Full Text] [Related]
23. Antiplatelet Therapy in Breast Cancer Patients Using Hormonal Therapy: Myths, Evidence and Potentialities - Systematic Review.
Leite AM; Macedo AVS; Jorge AJL; Martins WA
Arq Bras Cardiol; 2018 Aug; 111(2):205-212. PubMed ID: 30183988
[TBL] [Abstract][Full Text] [Related]
24. Antiplatelet effects of clopidogrel compared with aspirin after myocardial infarction: enhanced inhibitory effects of combination therapy.
Moshfegh K; Redondo M; Julmy F; Wuillemin WA; Gebauer MU; Haeberli A; Meyer BJ
J Am Coll Cardiol; 2000 Sep; 36(3):699-705. PubMed ID: 10987587
[TBL] [Abstract][Full Text] [Related]
25. New antiplatelet drugs: beyond aspirin and clopidogrel.
Siddique A; Butt M; Shantsila E; Lip GY
Int J Clin Pract; 2009 May; 63(5):776-89. PubMed ID: 19392926
[TBL] [Abstract][Full Text] [Related]
26. Antiplatelet Therapy in Acute Mild-Moderate Ischemic Stroke (ATAMIS): a parallel, randomised, open-label, multicentre, prospective study.
Hou X; Li X; Wang X; Chen H
Stroke Vasc Neurol; 2018 Dec; 3(4):263-267. PubMed ID: 30637134
[TBL] [Abstract][Full Text] [Related]
27. Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.
Margolese RG; Cecchini RS; Julian TB; Ganz PA; Costantino JP; Vallow LA; Albain KS; Whitworth PW; Cianfrocca ME; Brufsky AM; Gross HM; Soori GS; Hopkins JO; Fehrenbacher L; Sturtz K; Wozniak TF; Seay TE; Mamounas EP; Wolmark N
Lancet; 2016 Feb; 387(10021):849-56. PubMed ID: 26686957
[TBL] [Abstract][Full Text] [Related]
28. Risk of Hematoma From Aspirin or Clopidogrel Owing to Lumbar Puncture.
Lee PW; Levy M
Mayo Clin Proc; 2019 Aug; 94(8):1552-1555. PubMed ID: 31378231
[TBL] [Abstract][Full Text] [Related]
29. Atopaxar: a review of its mechanism of action and role in patients with coronary artery disease.
Rollini F; Tello-Montoliu A; Angiolillo DJ
Future Cardiol; 2012 Jul; 8(4):503-11. PubMed ID: 22871190
[TBL] [Abstract][Full Text] [Related]
30. Very Short Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients With High Bleeding Risk: Insight From the STOPDAPT-2 Trial.
Watanabe H; Domei T; Morimoto T; Natsuaki M; Shiomi H; Toyota T; Ohya M; Suwa S; Takagi K; Nanasato M; Hata Y; Yagi M; Suematsu N; Yokomatsu T; Takamisawa I; Doi M; Noda T; Okayama H; Seino Y; Tada T; Sakamoto H; Hibi K; Abe M; Kawai K; Nakao K; Ando K; Tanabe K; Ikari Y; Hanaoka KI; Morino Y; Kozuma K; Kadota K; Furukawa Y; Nakagawa Y; Kimura T;
Circulation; 2019 Dec; 140(23):1957-1959. PubMed ID: 31560216
[No Abstract] [Full Text] [Related]
31. Assessment and management of bone health in women with early breast cancer receiving endocrine treatment in the DATA study.
van Hellemond IEG; Smorenburg CH; Peer PGM; Swinkels ACP; Seynaeve CM; van der Sangen MJC; Kroep JR; de Graaf H; Honkoop AH; Erdkamp FLG; van den Berkmortel FWPJ; de Boer M; de Roos WK; Linn SC; Imholz ALT; Tjan-Heijnen VCG;
Int J Cancer; 2019 Sep; 145(5):1325-1333. PubMed ID: 30748011
[TBL] [Abstract][Full Text] [Related]
32. Solid cancers after antiplatelet therapy: Confirmations, controversies, and challenges.
Serebruany VL; Cherepanov V; Cabrera-Fuentes HA; Kim MH
Thromb Haemost; 2015 Nov; 114(6):1104-12. PubMed ID: 26559427
[TBL] [Abstract][Full Text] [Related]
33. Continuation of Dual Antiplatelet Therapy in a Patient with a Coronary Artery Stent with Dengue Hemorrhagic Fever: A Clinical Conundrum.
Ehelepola NDB; Athurupana AASD; Bowatte PGCS; Dissanayake WP
Am J Trop Med Hyg; 2020 Jan; 102(1):17-19. PubMed ID: 31701855
[TBL] [Abstract][Full Text] [Related]
34. Safety and tolerability of atopaxar in the treatment of patients with acute coronary syndromes: the lessons from antagonizing the cellular effects of Thrombin–Acute Coronary Syndromes Trial.
O'Donoghue ML; Bhatt DL; Wiviott SD; Goodman SG; Fitzgerald DJ; Angiolillo DJ; Goto S; Montalescot G; Zeymer U; Aylward PE; Guetta V; Dudek D; Ziecina R; Contant CF; Flather MD;
Circulation; 2011 May; 123(17):1843-53. PubMed ID: 21502577
[TBL] [Abstract][Full Text] [Related]
35. Antiplatelet effects of clopidogrel and aspirin after interventional patent foramen ovale/ atrium septum defect closure.
Polzin A; Dannenberg L; Sophia Popp V; Kelm M; Zeus T
Platelets; 2016 Jun; 27(4):317-21. PubMed ID: 26556101
[TBL] [Abstract][Full Text] [Related]
36. Effects of Edoxaban on the Cellular and Protein Phase of Coagulation in Patients with Coronary Artery Disease on Dual Antiplatelet Therapy with Aspirin and Clopidogrel: Results of the EDOX-APT Study.
Franchi F; Rollini F; Garcia E; Rivas Rios J; Rivas A; Agarwal M; Kureti M; Nagaraju D; Wali M; Briceno M; Moon JY; Kairouz V; Yaranov D; Been L; Suryadevara S; Soffer D; Zenni MM; Bass TA; Angiolillo DJ
Thromb Haemost; 2020 Jan; 120(1):83-93. PubMed ID: 31470444
[TBL] [Abstract][Full Text] [Related]
37. Platelet transfusion reverses bleeding evoked by triple anti-platelet therapy including vorapaxar, a novel platelet thrombin receptor antagonist.
Cai TQ; Wickham LA; Sitko G; Michener MS; Raubertas R; Handt L; Chintala M; Seiffert D; Forrest M
Eur J Pharmacol; 2015 Jul; 758():107-14. PubMed ID: 25857224
[TBL] [Abstract][Full Text] [Related]
38. Antiplatelet drugs and breast cancer risk in a large nationwide Danish case-control study.
Cairat M; Pottegård A; Olesen M; Dossus L; Fournier A; Hicks B
Int J Cancer; 2023 Apr; 152(7):1337-1347. PubMed ID: 36346115
[TBL] [Abstract][Full Text] [Related]
39. Dual antiplatelet Tx for stroke prevention: Worth the risk?
Helmer RS; Helmer AM; Smithgall S
J Fam Pract; 2020; 69(6):272-279. PubMed ID: 32724907
[TBL] [Abstract][Full Text] [Related]
40. Vitamin D levels and platelet reactivity in diabetic patients receiving dual antiplatelet therapy.
Verdoia M; Pergolini P; Nardin M; Rolla R; Negro F; Kedhi E; Suryapranata H; Marcolongo M; Carriero A; De Luca G;
Vascul Pharmacol; 2019 Sep; 120():106564. PubMed ID: 31176855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
